Page last updated: 2024-09-03

indatraline and 1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine

indatraline has been researched along with 1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine in 1 studies

Compound Research Comparison

Studies
(indatraline)
Trials
(indatraline)
Recent Studies (post-2010)
(indatraline)
Studies
(1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine)
Trials
(1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine)
Recent Studies (post-2010) (1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine)
460246405

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hurd, YL; Ungerstedt, U1

Other Studies

1 other study(ies) available for indatraline and 1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine

ArticleYear
In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen.
    European journal of pharmacology, 1989, Jul-18, Volume: 166, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Caudate Nucleus; Dialysis; Dopamine; Dopamine Agents; Homovanillic Acid; Indans; Male; Methylphenidate; Neurotransmitter Uptake Inhibitors; Nomifensine; Piperazines; Putamen; Rats; Rats, Inbred Strains

1989